Transdermal methylphenidate (Daytrana) for ADHD.
D000279:Administration, Cutaneous; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D002648:Child; D004334:Drug Administration Schedule; D017277:Drug Approval; D004347:Drug Interactions; D006801:Humans; D008774:Methylphenidate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D000697:Central Nervous System Stimulants; D008774:Methylphenidate